21 Hrs
Source:
المشهد العربي
Abivax shares rise on IBD drug results
Shares of the French pharmaceutical company "AbbVax" jumped by 25.8% after the release of promising data regarding their drug for treating intestinal diseases. This increase came to offset losses of around 44% that occurred in June, following a reduction in concerns about the drug's link to cancerous tumors. Recent results showed that the incidence rates were consistent with normal levels, which boosted investor confidence.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)